<DOC>
	<DOC>NCT02580903</DOC>
	<brief_summary>This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis. All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association. All patients will be followed up for a total of five years to identify prognosis.</brief_summary>
	<brief_title>Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<criteria>Myeloproliferative Neoplasms (PV, ET, PMF according to WHO classification) Pregnancy Lack of informed consent Age &lt; 18 years Cognitive dysfunctions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>